# The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults

> **NCT02228005** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 25 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT02228005
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02228005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02228005, "The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02228005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*